Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study

Table 1

Baseline demographics and surgical details of patients treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

		All patients ()	GYN ()	Digestive ()	value
Demographics	Median age (years)	66 (59–73)	67 (63–74)	62 (55–72)	0.193
	Gender (male)	8 (19%)	—	8	—
	Median BMI (kg/m^2)	22.5 (20–25)	23 (21–28)	22 (19–25)	0.116
	BMI < 18.5 kg/m^2	2 (5%)	0	2	—
	ECOG (0-1)	36 (86%)	20 (95%)	76 (90%)	0.077
		All PIPAC ()	GYN ()	Digestive ()	value
Intra-OP findings	PCI	10 (5–17)	9 (4–14)	15 (7–19)	0.002
	Ascites (mL)	50 (0–4000)	0 (0–300)	50 (0–4000)	0.034
	Adhesions	15 (16%)	9 (18%)	6 (15%)	0.735
	Operation time (min)	94 (89–108)	91 (87–97)	100 (92–117)	0.002

Median (IQR) or number of (%) as appropriate. Statistical significance () is highlighted in bold.
BMI: Body Mass Index; ECOG: Eastern Cooperative Oncology Group performance status [20]; PCI: Peritoneal Cancer Index [16].